Esther Masih-Khan
10PUBLICATIONS
28CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Mar 11, 2026
Debulking Chemotherapy Can Overcome Primary Resistance to Teclistamab in Relapsed/Refractory Multiple Myeloma.Rintu Sharma, Andree-Anne Pelland, Katherine Lajkosz
|May 12, 2025
A Single-Center Study on Frontline Treatment for Multiple Myeloma Patients With 1q Abnormalities.Ashish Patel, Esther Masih-Khan, Adam Smith
|Aug 13, 2023
Outcome of carfilzomib/pomalidomide-based regimens after daratumumab-based treatment in relapsed multiple myeloma: A Canadian Myeloma Research Group Database analysis.Richard LeBlanc, Hira Mian, Donna Reece
|Dec 05, 2022
Carfilzomib usage patterns and outcomes in patients with relapsed multiple myeloma: A multi-institutional report from the Canadian Myeloma Research Group (CMRG) Database.Arleigh McCurdy, Martha Louzada, Christopher P Venner
|Sep 26, 2022
Real-world data on lenalidomide dosing and outcomes in patients newly diagnosed with multiple myeloma: Results from the Canadian Myeloma Research Group Database.Hira Mian, Richard LeBlanc, Martha Louzada
|Mar 24, 2022
Sequential Use of Carfilzomib and Pomalidomide in Relapsed Multiple Myeloma: A Report from the Canadian Myeloma Research Group (CMRG) Database.Arleigh McCurdy, Christopher P Venner, Esther Masih-Khan
Pageof 2
Frequent Collaborators
3 joint publications
Victor Jimenez-Zepeda
3 joint publications
Tony Reiman
2 joint publications
Hannah M Cherniawsky
2 joint publications
Richard LeBlanc
2 joint publications
Hira Mian
2 joint publications
Donna Reece
2 joint publications
Christine I Chen
2 joint publications
Christopher Venner
1 joint publications
Victor H Jimenez-Zepeda
1 joint publications
Eyal Lebel
